memo - Magazine of European Medical Oncology

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

JAK2 Mutations in Polycythemia Vera: From Molecular Origins to Inflammatory Pathways and Clinical Implications

A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES Report from the American Society of Hematology (ASH) Annual Meeting, December 7–10, 2024

A GLOBAL CONGRESS DIGEST ON LUNG CANCER Report from the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer, September 7th –10th , hybrid congress

A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES Report from the European Hematology Association (EHA) 2024 Congress (hybrid), 13th – 16th June 2024

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 9–12, 2023

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ESMO Hybrid Congress , 20th – 24th October 2023, Madrid, Spain

A GLOBAL CONGRESS DIGEST ON CHRONIC LYMPHOCYTIC LEUKEMIA. Report from International Workshop on Chronic Lymphocytic Leukemia (XX iwCLL 2023), 6th–9th October, 2023, Boston, USA

A CONGRESS DIGEST ON RADIOLABELED THERANOSTICS FOR SOLID TUMORS. Report from the 36th Annual Congress of the European Association of Nuclear Medicine (EANM), September 9th – 13th, 2023, Vienna

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer, September 9th-12th , hybrid congress

A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Clinical Oncology (ASCO) Annual Meeting (hybrid), 2nd-6th June 2023, European Hematology Association (EHA) 2023 Congress (hybrid), 8th-11th June 2023, and the 17th International Conference on Malignant Lymphoma (ICML) 2023 Congress (hybrid), 13th-17th June 2023

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ASCO Hybrid Congress , 2nd – 6th June 2023

A CONGRESS DIGEST ON RADIOLABELED THERANOSTICS FOR SOLID TUMORS. Report from the 35th Annual Congress of the European Association of Nuclear Medicine (EANM), October 15th – 19th, 2022, Barcelona

A CONGRESS DIGEST ON NEUROENDOCRINE TUMORS. Report from the North American Neuroendocrine Tumor Society (NANETS) Annual Medical Symposium, 27th – 29th October 2022, Washington

A GLOBAL CONGRESS DIGEST ON APPROACHES IN ADVANCED SOLID TUMORS. Report from the ESMO Immuno-Oncology Congress, 7th – 9th December 2022

A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES AND AML. Report from the American Society of Hematology (ASH) Annual Meeting, December 10–13, 2022

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

A GLOBAL CONGRESS DIGEST ON WALDENSTRÖM‘S MACROGLOBULINEMIA. Report from the 11th International Workshop on Waldenström‘s Macroglobulinemia, 27th–30th October, 2022

A GLOBAL CONGRESS DIGEST ON IMMUNE-DIRECTED THERAPIES IN HODGKIN LYMPHOMA. Report from the International Symposium on Hodgkin lymphoma (ISHL12), 22nd–24th October 2022 (hybrid)

A GLOBAL CONGRESS DIGEST ON SOLID TUMORS. Report from the ESMO Hybrid Congress , 9th – 13th September 2022

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ESMO Hybrid Congress , 9th – 13th September 2022

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the International Association for the Study of Lung Cancer (IASLC) 2022 World Conference on Lung Cancer (WCLC), August 6th–9th, 2022

A GLOBAL CONGRESS DIGEST ON TARGETED AND IMMUNE-DIRECTED THERAPIES IN HAEMATOLOGICAL MALIGNANCIES. Report from the American Society of Clinical Oncology (ASCO) Annual Meeting (hybrid), 2nd–6th June 2022, and the 30th European Hematology Association (EHA) 2022 Congress (hybrid), 9th–12th June 2022

A GLOBAL CONGRESS DIGEST ON SOLID TUMORS. Report from the ASCO Hybrid Congress , 3rd – 7th June 2022

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ASCO Hybrid Congress, 3rd – 7th June 2022

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the virtual European Lung Cancer Congress, 30th March–2nd April 2022

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 11–14, 2021

A GLOBAL DIGEST ON APPROACHES IN ADVANCED SOLID TUMORS. Report from the ESMO Immuno-Oncology Congress, 8th – 11th December 2021

Von der Knochenmarktransplantation zur Intensive Care Unit – Critical Care Report

A GLOBAL CONGRESS DIGEST ON SOLID TUMORS. Report from the ESMO Virtual Congress, 16th – 21st September 2021

Report from the virtual World Conference on Lung Cancer, 8th –14th September 2021, and the virtual ESMO Congress, 16th –21st September, 2021

Report from the Virtual Annual Meetings 2021 of the American Society of Clinical Oncology (ASCO), the European Hematology Association (EHA), and the International Conference on Malignant Lymphoma (ICML)

A GLOBAL CONGRESS DIGEST ON SOLID TUMORS. Report from the ASCO Virtual Congress, 4th –8th June 2021

Report on Lung Cancer from the ASCO 2021 virtual congress, June 4th–8th

Report from the WCLC 2020 virtual Congress, January 28th–31th,

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

Report from the virtual American Society of Hematology (ASH) Annual Meeting, December 5th–8th, 2020

A GLOBAL DIGEST ON APPROACHES IN ADVANCED SOLID TUMORS. Report from the ESMO 2020 Virtual Congress, September 19th – 21st, 2020

Report from the ESMO Virtual Congress, 19th –21st September 2020

Report from the Virtual Edition of the 25th European Hematology Association (EHA), Annual Congress 11th –21st June 2020

Report from the ASCO Virtual Congress, May 29th – 31st 2020

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

A GLOBAL DIGEST ON APPROACHES IN ADVANCED SOLID TUMORS. Report from the ESMO 2019 Congress, Barcelona, September 27th – October 1st 2019

Report from the ESMO 2019 Congress, Barcelona, September 27th - October 1st 2019

Report from the ASCO 2019 Congress, Chicago, May 31st – June 4th 2019

Report from the ELCC 2019 Congress, Geneva, April 10th-13th, 2019

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

Report from the ESMO 2018 Congress, Munich, October 19th–23rd, 2018

Report from the WCLC 2018 Congress, Toronto, September 23rd–26th, 2018

Report from the ASCO 2018 Congress, Chicago, June 1st-5th, 2018

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

Report from the WCLC 2017 Congress, Yokohama, 15th – 18th October, 2017

Report from the ESMO 2017 Congress, Madrid, September 8th–12th, 2017

Report from the ASCO 2017 Congress, Chicago, 2nd–6th June, 2017

Report from the ESMO 2016 Congress, Copenhagen, 7th-11th October, 2016

Report from the ASCO 2016 Congress, Chicago, 3rd-7th June, 2016

Report from the ESMO Asia 2015 Congress, Singapore, 18th–21st December, 2015

Report from the 18th ECCO- 40th ESMO European Cancer Congress, Vienna 25th–29th September 2015

Report from the Annual Meeting of the American Society of Clinical Oncology Chicago, 29th May - 2nd June 2015

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

Proceedings of the Annual Meetingof the Austrian Society of Haematology and Oncology

Proceedings of the 15th International Oncology Meeting (IOM) (Guest Editor: G. Gastl, Innsbruck)

DNA as target for cancer therapy Surgical approach to metastatic patients

Immunotherapy for cancer treatment, ASCO 2008 – Highlights

Personalized cancer medicine

Clinical Year in Review in Respiratory Medicine 2008

Neurooncological Update 2008 (Editor: H. Kostron)

(Neo)-Adjuvant therapies and maintenance strategies: calculated risks to save lives

Austrian Society of Haematology and Oncology (Editor: G. Gastl)

Anti-angiogenic therapies are coming of age in clinical oncology and haematology